https://www.biospace.com/press-releases/benitec-biopharma-releases-third-quarter-2025-financial-results
Benitec Biopharma Releases Third Quarter 2025 Financial Results - BioSpace
2025 financial resultsbenitec biopharmathird quarterreleases
https://www.biospace.com/benitec-biopharma-announces-2020-annual-stockholder-meeting
Benitec Biopharma Announces 2020 Annual Stockholder Meeting - BioSpace
Dec 7, 2020 - Benitec Biopharma, Inc. (NASDAQ: BNTC), today announced that its 2020 Annual Meeting of Stockholders will be held virtually on Wednesday December 9, 2020 at 3...
benitec biopharmaannounces2020annualstockholder
https://www.biospace.com/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference
Benitec Biopharma to Present at the JMP Securities Life Sciences Conference - BioSpace
May 8, 2023 - Benitec Biopharma Inc. today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP...
benitec biopharma
https://www.upguard.com/security-report/benitec
Benitec Biopharma Security Rating, Vendor Risk Report, and Data Breaches | UpGuard
Compare Benitec Biopharma's security performance with other companies. Learn about data breaches, cyber attacks, and security incidents involving Benitec...
benitec biopharmasecurity ratingvendor riskdata breaches
https://www.biospace.com/press-releases/benitec-biopharma-releases-second-quarter-2025-financial-results-and-provides-operational-update
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update -...
2025 financial resultsbenitec biopharmasecond quarter
https://robinhood.com/us/en/stocks/BNTCW/
Benitec Biopharma (Warrant): BNTCW Stock Price Quote & News | Robinhood
You can watch BNTCW and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying...
benitec biopharmastock pricewarrantquotenews
https://investingnews.com/benitec-biopharma-announces-appointment-of-sharon-mates-ph-d-to-its-board-of-directors/
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors | INN
Nov 3, 2025 - Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic...
https://www.biospace.com/press-releases/benitec-biopharma-reports-positive-interim-clinical-results-for-three-subjects-treated-with-bb-301-in-phase-1b-2a-study-to-be-presented-at-the-2025-muscular-dystrophy-association-clinical-scientific-conference
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301...
https://investingnews.com/benitec-biopharma-releases-full-year-2025-financial-results-and-provides-operational-update/
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update | INN
Sep 22, 2025 - Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025 Enrollment of the First Subject into Cohort 2 of...
2025 financial results
https://www.benzinga.com/trading-ideas/movers/23/08/33673922/12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benitec Biopharma (NASDAQ:BNTC),...